NextCure, Inc.
Edit

NextCure, Inc.

http://nextcure.com/
Last activity: 04.10.2022
Tags:BioTechDevelopmentDrugInterestPlatformProductResearchTechnology
NextCure is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. We view the immune system holistically and, rather than target one specific immune cell type, we focus on understanding biological pathways, the interactions of cells and the role each interaction plays in an immune response. Through our proprietary Functional, Integrated, NextCure Discovery in Immuno-Oncology, or FIND-IO, platform, we study various immune cells to discover and understand targets and structural components of immune cells and their functional impact in order to develop immunomedicines. We are focused on patients who do not respond to current therapies, patients whose cancer progresses despite treatment and patients with cancer types not adequately addressed by available therapies.
Mentions
11
Location: United States, Maryland, Beltsville
Employees: 51-200
Total raised: $160M
Founded date: 2015

Investors 7

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
13.11.2018Series B$93M-vcnewsdail...
06.01.2016Series A$67M-vcnewsdail...

Mentions in press and media 11

DateTitleDescriptionSource
04.10.2022ROTH Capital Partners to Host Inaugural Healthcare Opportuni...Event to feature company presentations and one-on-one meetings between institutional investors and s...einpresswi...
19.10.2021NextCure : Announces Three New Members of its Scientific Adv...BELTSVILLE, Md., Oct. 19, 2021 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage b...marketscre...
04.10.2021NextCure : Announces New Appointments to its Board of Direct...BELTSVILLE, Md., Oct. 04, 2021 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage b...marketscre...
04.10.2021NextCure : Announces New Appointments to its Board of Direct...NextCure Announces New Appointments to its Board of Directors BELTSVILLE, Md., October 4, 2021 - Ne...marketscre...
09.05.2019Four biotech companies announce pricings of IPOs, looking to...NextCure, based in Beltsville, Maryland, said Wednesday that it had priced its IPO of 5 million shar...medcitynew...
13.11.2018NextCure Completes a $93M Series B Financing-sofinnova....
13.11.2018NextCure Nabs $93M Series B Funding BELTSVILLE, MD, NextCure today announced the completion of a $93 million series B equity financing...vcnewsdail...
13.11.2018NextCure Raises $93M In Series B FinancingBELTSVILLE, Md.--(BUSINESS WIRE)--NextCure Inc., a privately-held biopharmaceutical company discover...citybizlis...
06.01.2016NextCure Raises $67M in Series A FinancingNextCure, Inc., a newly formed biopharmaceutical company focused on the discovery and development of...finsmes.co...
06.01.2016NextCure Announces $67M in Series A announced that it has raised a $67 million Series A financing. >> Click here for more fundi...vcnewsdail...
Show more